Fabio Bignami Selected Research

befetupitant

9/2014

NK1 receptor antagonists as a new treatment for corneal neovascularization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fabio Bignami Research Topics

Disease

7	Burns 01/2018 - 03/2013
5	Corneal Neovascularization 01/2018 - 04/2014
3	Corneal Opacity 11/2017 - 03/2013
3	Inflammation (Inflammations) 01/2016 - 08/2014
2	Corneal Perforation 09/2014 - 03/2013
1	Pain (Aches) 01/2021
1	Conjunctivitis 11/2017
1	Hyperemia 11/2015
1	Edema (Dropsy) 03/2015
1	Cicatrix (Scar) 03/2013
1	Fibrosis (Cirrhosis) 03/2013
1	Phimosis 03/2013
1	Infections 06/2012

Drug/Important Bio-Agent (IBA)

7	AlkaliesIBA 01/2018 - 03/2013
5	Substance PIBA 01/2021 - 08/2014
3	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 01/2021 - 01/2016
2	fosaprepitant FDA Link 01/2021 - 11/2017
2	NeuropeptidesIBA 01/2016 - 08/2014
2	Infliximab (Remicade)FDA Link 03/2015 - 03/2013
1	Fluorescein (Funduscein)FDA LinkGeneric 11/2017
1	Therapeutic UsesIBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 11/2015
1	CytokinesIBA 03/2015
1	Adalimumab (Humira)FDA Link 03/2015
1	Etanercept (Enbrel)FDA Link 03/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2015
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 09/2014
1	befetupitantIBA 09/2014
1	TachykininsIBA 09/2014
1	1- (N- (2- methoxybenzyl)acetylamino)- 3- (1H- indol- 3- yl)- 2- (N- (2- (4- (piperidin- 1- yl)piperidin- 1- yl)acetyl)amino)propane (Lanepitant)IBA 09/2014
1	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 08/2014
1	Monoclonal AntibodiesIBA 03/2013
1	MicroRNAs (MicroRNA)IBA 06/2012

Therapy/Procedure

4	Sutures (Suture) 01/2018 - 04/2014
1	Topical Administration 09/2014
1	Slit Lamp 03/2013